A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies

Filipa Lynce, Hongkun Wang, Emanuel F. Petricoin, Paula R. Pohlmann, Brandon Smaglo, Jimmy Hwang, Aiwu R. He, Deepa S. Subramaniam, John Deeken, John Marshall, Michael J. Pishvaian

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry